Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b
Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-α 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypoto...
Gespeichert in:
| Veröffentlicht in: | International journal of pharmaceutics 2007-08, Vol.341 (1), p.125-133 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 133 |
|---|---|
| container_issue | 1 |
| container_start_page | 125 |
| container_title | International journal of pharmaceutics |
| container_volume | 341 |
| creator | Hamidi, M. Zarrin, A.H. Foroozesh, M. Zarei, N. Mohammadi-Samani, S. |
| description | Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-α 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33
±
588.35
IU/0.1
ml, 14.53
±
2.94%, and 83.61
±
0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized
in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested
in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug. |
| doi_str_mv | 10.1016/j.ijpharm.2007.04.001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68095629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517307003018</els_id><sourcerecordid>68095629</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-4cbaac776c3a9620c907dcd900cbbcc810a6f17d5da18c9f52d75842173c6a5b3</originalsourceid><addsrcrecordid>eNqFkE2LFDEQhoMo7rj6E5Rc9NZtpT-S7pPIsrrCguLHOaQr1W6Gns5Y6RmYf2-GadjjngrC86beeoR4q6BUoPTHbRm2-wfHu7ICMCU0JYB6JjaqM3VRN0Y_FxuoTVe0ytRX4lVKWwDQlapfiitlWlXprt2I6QfT3rFbQpylm70MszyGhaOko5sOl_c4SnTMgVgSn5YHjnhaKMkxsvx5-6tYHP-lhbz0NIVjRs6JMC_EI3GcCzflprIaXosXo5sSvVnntfjz5fb3zV1x__3rt5vP9wXWfb0UDQ7OoTEaa9frCrAH49H3ADgMiJ0Cp0dlfOud6rAf28qbtmuqfChq1w71tfhw-XfP8d-B0mJ3ISFNk5spHpLVHfStrvoMthcQOabENNo9h53jk1Vgz5rt1q6a7VmzhcZmzTn3bl1wGHbkH1Or1wy8XwGX0E0juxlDeuS6PncwkLlPF46yjmMWbBMGmpF8YMLF-hieqPIfy1Cf6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68095629</pqid></control><display><type>article</type><title>Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hamidi, M. ; Zarrin, A.H. ; Foroozesh, M. ; Zarei, N. ; Mohammadi-Samani, S.</creator><creatorcontrib>Hamidi, M. ; Zarrin, A.H. ; Foroozesh, M. ; Zarei, N. ; Mohammadi-Samani, S.</creatorcontrib><description>Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-α 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33
±
588.35
IU/0.1
ml, 14.53
±
2.94%, and 83.61
±
0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized
in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested
in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2007.04.001</identifier><identifier>PMID: 17512685</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult ; Biological and medical sciences ; Carrier erythrocytes ; Chemistry, Pharmaceutical ; Drug Carriers ; Drug Compounding ; Erythrocyte Deformability ; Erythrocyte Indices ; Erythrocytes - chemistry ; Erythrocytes - metabolism ; Erythrocytes - ultrastructure ; Feasibility Studies ; General pharmacology ; Hemoglobins - metabolism ; Hemolysis ; Humans ; Hypotonic preswelling ; Hypotonic Solutions ; In Vitro Techniques ; Interferon ; Interferon-alpha - chemistry ; Interferon-alpha - metabolism ; Interferon-α 2b ; Kinetics ; Medical sciences ; Microscopy, Electron, Scanning ; Mononuclear Phagocyte System - metabolism ; Osmotic Fragility ; Osmotic Pressure ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Recombinant Proteins ; Reproducibility of Results ; Solubility ; Technology, Pharmaceutical - methods</subject><ispartof>International journal of pharmaceutics, 2007-08, Vol.341 (1), p.125-133</ispartof><rights>2007 Elsevier B.V.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-4cbaac776c3a9620c907dcd900cbbcc810a6f17d5da18c9f52d75842173c6a5b3</citedby><cites>FETCH-LOGICAL-c393t-4cbaac776c3a9620c907dcd900cbbcc810a6f17d5da18c9f52d75842173c6a5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2007.04.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18968070$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17512685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamidi, M.</creatorcontrib><creatorcontrib>Zarrin, A.H.</creatorcontrib><creatorcontrib>Foroozesh, M.</creatorcontrib><creatorcontrib>Zarei, N.</creatorcontrib><creatorcontrib>Mohammadi-Samani, S.</creatorcontrib><title>Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-α 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33
±
588.35
IU/0.1
ml, 14.53
±
2.94%, and 83.61
±
0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized
in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested
in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Carrier erythrocytes</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug Carriers</subject><subject>Drug Compounding</subject><subject>Erythrocyte Deformability</subject><subject>Erythrocyte Indices</subject><subject>Erythrocytes - chemistry</subject><subject>Erythrocytes - metabolism</subject><subject>Erythrocytes - ultrastructure</subject><subject>Feasibility Studies</subject><subject>General pharmacology</subject><subject>Hemoglobins - metabolism</subject><subject>Hemolysis</subject><subject>Humans</subject><subject>Hypotonic preswelling</subject><subject>Hypotonic Solutions</subject><subject>In Vitro Techniques</subject><subject>Interferon</subject><subject>Interferon-alpha - chemistry</subject><subject>Interferon-alpha - metabolism</subject><subject>Interferon-α 2b</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Microscopy, Electron, Scanning</subject><subject>Mononuclear Phagocyte System - metabolism</subject><subject>Osmotic Fragility</subject><subject>Osmotic Pressure</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Recombinant Proteins</subject><subject>Reproducibility of Results</subject><subject>Solubility</subject><subject>Technology, Pharmaceutical - methods</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2LFDEQhoMo7rj6E5Rc9NZtpT-S7pPIsrrCguLHOaQr1W6Gns5Y6RmYf2-GadjjngrC86beeoR4q6BUoPTHbRm2-wfHu7ICMCU0JYB6JjaqM3VRN0Y_FxuoTVe0ytRX4lVKWwDQlapfiitlWlXprt2I6QfT3rFbQpylm70MszyGhaOko5sOl_c4SnTMgVgSn5YHjnhaKMkxsvx5-6tYHP-lhbz0NIVjRs6JMC_EI3GcCzflprIaXosXo5sSvVnntfjz5fb3zV1x__3rt5vP9wXWfb0UDQ7OoTEaa9frCrAH49H3ADgMiJ0Cp0dlfOud6rAf28qbtmuqfChq1w71tfhw-XfP8d-B0mJ3ISFNk5spHpLVHfStrvoMthcQOabENNo9h53jk1Vgz5rt1q6a7VmzhcZmzTn3bl1wGHbkH1Or1wy8XwGX0E0juxlDeuS6PncwkLlPF46yjmMWbBMGmpF8YMLF-hieqPIfy1Cf6Q</recordid><startdate>20070816</startdate><enddate>20070816</enddate><creator>Hamidi, M.</creator><creator>Zarrin, A.H.</creator><creator>Foroozesh, M.</creator><creator>Zarei, N.</creator><creator>Mohammadi-Samani, S.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070816</creationdate><title>Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b</title><author>Hamidi, M. ; Zarrin, A.H. ; Foroozesh, M. ; Zarei, N. ; Mohammadi-Samani, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-4cbaac776c3a9620c907dcd900cbbcc810a6f17d5da18c9f52d75842173c6a5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Carrier erythrocytes</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug Carriers</topic><topic>Drug Compounding</topic><topic>Erythrocyte Deformability</topic><topic>Erythrocyte Indices</topic><topic>Erythrocytes - chemistry</topic><topic>Erythrocytes - metabolism</topic><topic>Erythrocytes - ultrastructure</topic><topic>Feasibility Studies</topic><topic>General pharmacology</topic><topic>Hemoglobins - metabolism</topic><topic>Hemolysis</topic><topic>Humans</topic><topic>Hypotonic preswelling</topic><topic>Hypotonic Solutions</topic><topic>In Vitro Techniques</topic><topic>Interferon</topic><topic>Interferon-alpha - chemistry</topic><topic>Interferon-alpha - metabolism</topic><topic>Interferon-α 2b</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Microscopy, Electron, Scanning</topic><topic>Mononuclear Phagocyte System - metabolism</topic><topic>Osmotic Fragility</topic><topic>Osmotic Pressure</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Recombinant Proteins</topic><topic>Reproducibility of Results</topic><topic>Solubility</topic><topic>Technology, Pharmaceutical - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamidi, M.</creatorcontrib><creatorcontrib>Zarrin, A.H.</creatorcontrib><creatorcontrib>Foroozesh, M.</creatorcontrib><creatorcontrib>Zarei, N.</creatorcontrib><creatorcontrib>Mohammadi-Samani, S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamidi, M.</au><au>Zarrin, A.H.</au><au>Foroozesh, M.</au><au>Zarei, N.</au><au>Mohammadi-Samani, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2007-08-16</date><risdate>2007</risdate><volume>341</volume><issue>1</issue><spage>125</spage><epage>133</epage><pages>125-133</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-α 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33
±
588.35
IU/0.1
ml, 14.53
±
2.94%, and 83.61
±
0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized
in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested
in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>17512685</pmid><doi>10.1016/j.ijpharm.2007.04.001</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-5173 |
| ispartof | International journal of pharmaceutics, 2007-08, Vol.341 (1), p.125-133 |
| issn | 0378-5173 1873-3476 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68095629 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adult Biological and medical sciences Carrier erythrocytes Chemistry, Pharmaceutical Drug Carriers Drug Compounding Erythrocyte Deformability Erythrocyte Indices Erythrocytes - chemistry Erythrocytes - metabolism Erythrocytes - ultrastructure Feasibility Studies General pharmacology Hemoglobins - metabolism Hemolysis Humans Hypotonic preswelling Hypotonic Solutions In Vitro Techniques Interferon Interferon-alpha - chemistry Interferon-alpha - metabolism Interferon-α 2b Kinetics Medical sciences Microscopy, Electron, Scanning Mononuclear Phagocyte System - metabolism Osmotic Fragility Osmotic Pressure Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Recombinant Proteins Reproducibility of Results Solubility Technology, Pharmaceutical - methods |
| title | Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preparation%20and%20in%20vitro%20evaluation%20of%20carrier%20erythrocytes%20for%20RES-targeted%20delivery%20of%20interferon-alpha%202b&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Hamidi,%20M.&rft.date=2007-08-16&rft.volume=341&rft.issue=1&rft.spage=125&rft.epage=133&rft.pages=125-133&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2007.04.001&rft_dat=%3Cproquest_cross%3E68095629%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68095629&rft_id=info:pmid/17512685&rft_els_id=S0378517307003018&rfr_iscdi=true |